GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dignitana AB (OSTO:DIGN) » Definitions » Capital Expenditure

Dignitana AB (OSTO:DIGN) Capital Expenditure : kr-6.90 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Dignitana AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Dignitana AB's cash flow for capital expenditures for the three months ended in Mar. 2024 was kr-2.09 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was kr-6.90 Mil.


Dignitana AB Capital Expenditure Historical Data

The historical data trend for Dignitana AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dignitana AB Capital Expenditure Chart

Dignitana AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -21.52 -20.40 -10.56 -3.22 -4.60

Dignitana AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.76 -2.31 -1.05 -1.46 -2.09

Dignitana AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-6.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dignitana AB (OSTO:DIGN) Business Description

Traded in Other Exchanges
Address
Traktorgranden 3, Lund, SWE, 226 60
Dignitana AB is a medical technology company, that develops, produces, and markets The DigniCap Scalp Cooling System. It is a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy to improve well-being and quality of life. Geographically, it derives a majority of revenue from the USA.

Dignitana AB (OSTO:DIGN) Headlines

No Headlines